Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2008 1
2009 1
2015 2
2016 6
2017 5
2018 6
2019 9
2020 7
2021 6
2022 6
2023 4
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

44 results

Results by year

Filters applied: . Clear all
Page 1
Response to Letter to the Editor From Devgan and Mayilvaganan: "Natural History and Predictive Factors of Outcome in Medullary Thyroid Microcarcinoma".
Kesby N, Mechera R, Fuchs T, Papachristos A, Gild M, Tsang V, Clifton-Bligh R, Robinson B, Sywak M, Sidhu S, Chou A, Gill AJ, Glover A. Kesby N, et al. Among authors: mechera r. J Clin Endocrinol Metab. 2023 Dec 21;109(1):e437. doi: 10.1210/clinem/dgad380. J Clin Endocrinol Metab. 2023. PMID: 37379017 No abstract available.
Natural History and Predictive Factors of Outcome in Medullary Thyroid Microcarcinoma.
Kesby N, Mechera R, Fuchs T, Papachristos A, Gild M, Tsang V, Clifton-Bligh R, Robinson B, Sywak M, Sidhu S, Chou A, Gill AJ, Glover A. Kesby N, et al. Among authors: mechera r. J Clin Endocrinol Metab. 2023 Sep 18;108(10):2626-2634. doi: 10.1210/clinem/dgad173. J Clin Endocrinol Metab. 2023. PMID: 36964913 Free PMC article.
A high-throughput drug screen reveals means to differentiate triple-negative breast cancer.
Vulin M, Jehanno C, Sethi A, Correia AL, Obradović MMS, Couto JP, Coissieux MM, Diepenbruck M, Preca BT, Volkmann K, der Maur PA, Schmidt A, Münst S, Sauteur L, Kloc M, Palafox M, Britschgi A, Unterreiner V, Galuba O, Claerr I, Lopez-Romero S, Galli GG, Baeschlin D, Okamoto R, Soysal SD, Mechera R, Weber WP, Radimerski T, Bentires-Alj M. Vulin M, et al. Among authors: mechera r. Oncogene. 2022 Sep;41(39):4459-4473. doi: 10.1038/s41388-022-02429-0. Epub 2022 Aug 25. Oncogene. 2022. PMID: 36008466 Free PMC article.
Efficacy of intraoperative cholangiography versus preoperative magnetic resonance cholangiography in patients with intermediate risk for common bile duct stones.
Staubli SM, Kettelhack C, Oertli D, von Holzen U, Zingg U, Mattiello D, Rosenberg R, Mechera R, Rosenblum I, Pfefferkorn U, Kollmar O, Nebiker CA. Staubli SM, et al. Among authors: mechera r. HPB (Oxford). 2022 Nov;24(11):1898-1906. doi: 10.1016/j.hpb.2022.05.1346. Epub 2022 Jun 18. HPB (Oxford). 2022. PMID: 35817694 Free article. Clinical Trial.
Identification of TPM2 and CNN1 as Novel Prognostic Markers in Functionally Characterized Human Colon Cancer-Associated Stromal Cells.
Mele V, Basso C, Governa V, Glaus Garzon JF, Muraro MG, Däster S, Nebiker CA, Mechera R, Bolli M, Schmidt A, Geiger R, Spagnoli GC, Christoforidis D, Majno PE, Borsig L, Iezzi G. Mele V, et al. Among authors: mechera r. Cancers (Basel). 2022 Apr 16;14(8):2024. doi: 10.3390/cancers14082024. Cancers (Basel). 2022. PMID: 35454931 Free PMC article.
High ratio of pCXCR4/CXCR4 tumor infiltrating immune cells in primary high grade ovarian cancer is indicative for response to chemotherapy.
Walther F, Berther JL, Lalos A, Ramser M, Eichelberger S, Mechera R, Soysal S, Muenst S, Posabella A, Güth U, Stadlmann S, Terracciano L, Droeser RA, Zeindler J, Singer G. Walther F, et al. Among authors: mechera r. BMC Cancer. 2022 Apr 9;22(1):376. doi: 10.1186/s12885-022-09374-x. BMC Cancer. 2022. PMID: 35397601 Free PMC article.
44 results